JPRN-UMIN000010703已完成未知
The effects of vildagliptin in addition to insulin on glycemic control in hemodialysis patients with type 2 diabetes mellitus - The effects of vildagliptin in addition to insulin on glycemic control in hemodialysis patients with type 2 diabetes mellitus
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Severe ketosis, or diabetic coma or precoma, type1 diabetes 2) Severe liver dysfunction 3) Diarrhea or vomiting 4) Severe infection, before and after surgery, or severe trauma 5) History of lactic acidosis or pancreatitis 6) Severe cardiac or pulmonary dysfunction, such as shock, heart failure, myocardial infarction, and pulmonary embolism. 7) Dehydration 8) History of severe alcoholic abuse 9) Malnutrition, starvation, debility, pituitary dysfunction, and adrenal insufficiency 10) Pregnant female, female with possibility of pregnancy 11) Malignancy 12) History of hypersensitivity to targeted medication 13) Patients inappropriate for medical reason
研究者
相似试验
进行中（未招募）
不适用
Effect of adding vildagliptin to start of insulin treatment in combination with metformin in patients with type 2 diabetes - Effect of adding vildagliptin to insulin treatmentpatients with type 2 diabetes, failing on maximal oral glucose-lowering drugs, starting on insulin therapy in combination with standard metfromin (2 x 850)MedDRA version: 9.1Level: LLTClassification code 10012594Term: DiabetesEUCTR2009-010967-18-NLniversity Medical Centre Utrecht40
已完成
3 期
Effect of adding vildagliptin to start of insulin treatment in patients with type 2 diabetesDiabetesNL-OMON37974Academisch Medisch Centrum40
已完成
不适用
Effect of adding vildagliptin to start of insulin treatment in patients with type 2 diabetes.DiabetesNL-OMON29400MCUtrecht40
未知
3 期
Efficacy and safety of vildagliptin as add-on therapy to metformin in patients with type 2 diabetesType 2 diabetes mellitusJPRN-jRCT2080221679ovartis Pharma K.K.136
已完成
不适用
The efficacy of vildagliptin on type 2 diabetic patients with basal-bolus insulin therapy in the short-term hospitalization (single-center, randomized, open-label, controlled study).Type 2 DiabetesJPRN-UMIN000011851ippon Medical School, Chiba-Hokusoh Hospital, Division of Endocrinology, Department of Medicine40